Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate

AIM: Urinary pharmacokinetic methods have been identified to determine the relative lung and systemic bioavailability after an inhalation. We have extended this methodology to inhaled beclometasone dipropionate (BDP). METHOD: Ethics Committee approval was obtained and all subjects gave consent. Twel...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Said, Amira S A, Harding, Lindsay P, Chrystyn, Henry
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 2012
Sujets:
Pharmacokinetics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477347/
https://ncbi.nlm.nih.gov/pubmed/22299644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04210.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires